BridgeBio Pharma (BBIO) stock edges up after $550 million convertible notes pricing — what investors watch next
New York, January 16, 2026, 14:57 EST — Regular session Shares of BridgeBio Pharma Inc edged up 0.5% to $76.66 Friday afternoon, following the announcement of a $550 million convertible notes sale. The stock swung between $75.87 and $78.12, with roughly 5.9 million shares changing hands. (BridgeBio Investor Relations) This financing matters because it reshapes BridgeBio’s balance sheet in one…